
NYSEHealthcareMedical - Distribution
Latest quote
$938.84
+$8.59 · +0.92%
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
Latest quote
$938.84
+$8.59 · +0.92%
After-hours
$938.84
$0.00 · 0.00%
Oct 9, 4:04 PM ET
Regular session · ET · Market data may be delayed.
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
Day range
Current $938.84
52-week range
Current $938.84
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
75
Undervalued
Sentiment
63
Bullish
Risk
22
Moderate Risk
Momentum
47
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
Day range
Current $938.84
52-week range
Current $938.84
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 403.43B USD | 359.05B USD | 308.95B USD | 276.71B USD | 263.97B USD |
| Cost of goods sold | 388.88B USD | 346.57B USD | 296.75B USD | 264.84B USD | 251.32B USD |
| Gross profit | 14.55B USD | 12.49B USD | 12.2B USD | 11.87B USD | 12.65B USD |
| Research and development | 103M USD | 91M USD | 77M USD | 89M USD | 70M USD |
| Selling, general, and administrative | −8.1B USD | 8.02B USD | 8.2B USD | 7.33B USD | 9.86B USD |
| Operating expenses | 8.1B USD | 8.11B USD | 8.28B USD | 7.42B USD | 9.93B USD |
| Interest income | 179M USD | 173M USD | 118M USD | 107M USD | 10M USD |
| Interest expense | 247M USD | 256M USD | 243M USD | 248M USD | 178M USD |
| Depreciation and amortization | 729M USD | 636M USD | 635M USD | 608M USD | 760M USD |
| Operating income | 6.45B USD | 4.37B USD | 3.93B USD | 4.45B USD | 2.72B USD |
| Net income | 4.76B USD | 3.3B USD | 3B USD | 3.56B USD | 1.11B USD |
Company facts updated Oct 10, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$956.43
1.87% upsideCash distributions grouped by calendar year; partial years are marked.
$3.06
2025 complete year+71.9% since 2021
2026 partial: $2.58
$1.78
2,021
$2.02
2,022
$2.32
2,023
$2.66
2,024
$3.06
2,025
$2.58
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Sep 1, 2026 | $0.94Quarterly | Sep 1, 2026 | Oct 1, 2026 |
Dividend | Jun 1, 2026 | $0.82Quarterly | Jun 1, 2026 | Jul 1, 2026 |
Dividend | Mar 2, 2026 | $0.82Quarterly | Mar 2, 2026 | Apr 1, 2026 |
Dividend | Dec 1, 2025 | $0.82Quarterly | Dec 1, 2025 | Jan 2, 2026 |
Dividend | Sep 2, 2025 | $0.82Quarterly | Sep 2, 2025 | Oct 1, 2025 |
Dividend | Jun 2, 2025 | $0.71Quarterly | Jun 2, 2025 | Jul 1, 2025 |
Ex-dividend Sep 1, 2026
$0.94
Quarterly
Record Sep 1, 2026 · Payment Oct 1, 2026
Ex-dividend Jun 1, 2026
$0.82
Quarterly
Record Jun 1, 2026 · Payment Jul 1, 2026
Ex-dividend Mar 2, 2026
$0.82
Quarterly
Record Mar 2, 2026 · Payment Apr 1, 2026
Ex-dividend Dec 1, 2025
$0.82
Quarterly
Record Dec 1, 2025 · Payment Jan 2, 2026
Ex-dividend Sep 2, 2025
$0.82
Quarterly
Record Sep 2, 2025 · Payment Oct 1, 2025
Ex-dividend Jun 2, 2025
$0.71
Quarterly
Record Jun 2, 2025 · Payment Jul 1, 2025
Funds reporting this stock among their holdings, ordered by reported position size.
State Street SPDR S&P 500 ETF1557.T210.34B0.16%129.69T JPY0.09%¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI3.38B0.14%2.3T USD0.03%$381.94+0.63%
Vanguard S&P 500 ETFVOO2.83B0.16%1.8T USD0.03%$715.59+0.61%
iShares Core S&P 500 ETFIVV1.44B0.16%892.79B USD0.03%$781.97+0.60%
State Street SPDR S&P 500 ETFSPY1.33B0.16%821.54B USD0.09%$778.57+0.60%
Vanguard Morningstar Value ETFVTV1.02B0.39%262.4B USD0.03%$220.59+0.44%
State Street Health Care Select Sector SPDR ETFXLV771.45M1.77%43.48B USD0.08%$170.81+1.58%
Vanguard Dividend Appreciation ETFVIG602.41M0.45%132.4B USD0.04%$239.05+0.70%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLV
Vanguard Dividend Appreciation ETFVIGAI-generated and delayed market data for informational and educational purposes only. Not investment advice.